HudsonAlpha Journal - 2011, Volume 3, Issue 7
September 27, 2011
Bipolar: HudsonAlpha awarded major grant to advance research on devastating psychiatric disorder
The National Institute of Mental Health awarded nearly $6 million to HudsonAlpha for its part in a bipolar disorder study. Dr. Rick Myers, HudsonAlpha president and director, will be the lead investigator on the project, which will be done in collaboration with the University of Michigan. Read more.
First patent secured by HudsonAlpha for innovative multiplexing technology
The institute received its first patent. It applies to innovative technology, developed by Dr. Jian Han, that can be used to detect multiple pathogenic targets rapidly and accurately from a single diagnostic test. The technology is already in use by iCubate, a HudsonAlpha associate company. Read more.
Gregg Tyree joined the HudsonAlpha Institute for Biotechnology in January 2008. He helped oversee the completion of the 270,000 sq.-ft. campus and continues to supervise a growing facility, campus and staff. HudsonAlpha's consistent growth guarantees additional work for Tyree, which he fully embraces. Read more.
In good company: Conversant Bio, Inc.
HudsonAlpha has 16 resident associate companies. Eash has a unique niche in the biotech field and plays an important role in HudsonAlpha's efforts to grow and diversify the economy, while improving human health and quality of life. Will Taylor of Conversant Bio explains why his business is in good company at HudsonAlpha - in good times and in bad.
